Diisopropylethylamine → HCID 136983681, compound
Reaction equation
[O:1]([C:8]1[CH:13]=[CH:12][C:11]([C:14]2[C:28]([C:29]([NH2:31])=[O:30])=[C:17]3[NH:18][CH2:19][CH2:20][C@@H:21]([CH:22]4[CH2:27][CH2:26][NH:25][CH2:24][CH2:23]4)[N:16]3[N:15]=2)=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[C:32]([O:36][C:37]([NH:39][CH2:40][CH2:41][N:42]1[CH2:47][CH2:46][N:45]([CH2:48]/[CH:49]=[CH:50]/[C:51](O)=[O:52])[CH2:44][CH2:43]1)=[O:38])([CH3:35])([CH3:34])[CH3:33].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C>CN(C=O)C.O>[C:29]([C:28]1[C:14]([C:11]2[CH:10]=[CH:9][C:8]([O:1][C:2]3[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=3)=[CH:13][CH:12]=2)=[N:15][N:16]2[C@H:21]([CH:22]3[CH2:23][CH2:24][N:25]([C:51](=[O:52])/[CH:50]=[CH:49]/[CH2:48][N:45]4[CH2:46][CH2:47][N:42]([CH2:41][CH2:40][NH:39][C:37](=[O:38])[O:36][C:32]([CH3:33])([CH3:35])[CH3:34])[CH2:43][CH2:44]4)[CH2:26][CH2:27]3)[CH2:20][CH2:19][NH:18][C:17]=12)(=[O:30])[NH2:31]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of (S)-2-(4-phenoxyphenyl)-7-(piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (1.26 g, 3.03 mmol), (E)-4-(4-(2-((tert-butoxycarbonyl)amino)ethyl)piperazin-1-yl)but-2-enoic acid (948.4 mg, 3.03 mmol), HATU (1.21 g, 3.18 mmol), DIEA (782 mg, 6.06 mmol) in 30 mL of DMF was stirred at RT for 15 hr. The mixture was poured into 300 mL of water and extracted with EA (100 mL). The organic phase was washed with water (100 mL×3) and concentrated to give 1.25 g (58%) of product as a yellow solid. 1H NMR (400 MHz, DMSO-d6) δ 7.50 (d, J=8.4 Hz, 2H), 7.42 (t, J=8.4 Hz, 2H), 7.17 (t, J=7.4 Hz, 1H), 7.12-7.02 (m, 4H), 6.67 (br s, 1H), 6.64-6.53 (m, 3H), 4.53-4.40 (m, 1H), 4.14-4.05 (m, 1H), 3.32-3.25 (m, 2H), 3.10-2.91 (m, 5H), 2.45-2.15 (m, 1H), 2.10-2.00 (m, 1H), 1.96-1.84 (m, 1H), 1.78-1.65 (m, 1H), 1.62-1.50 (m, 1H), 1.37 (s, 9H), 1.31-1.10 (m, 3H). MS (ESI) m/e [M+1]+713.0.
Workup
- extractionextracted with EA (100 mL)
- washThe organic phase was washed with water (100 mL×3)
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-ed12894827794d7c932928b4cc46438b
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09447106B2
Reaction notes
Loading…